Abstract
Objective: NA
Background: We present a 67 year old man admitted with progressive generalized weakness and altered mental status, found to have autoimmune encephalitis after his CSF tested positive for a rare onconeural antibody Zic4. Patients with Zic4 antibodies have been found to present with a cerebellar syndrome which correlated with his MRI brain findings of generalized atrophy, most prominent in the cerebellum, that were not present on previous scans. The malignancy survey was negative in his case. He failed multiple first line therapies including intravenous immunoglobulin (IVIG) and plasmapheresis with subsequent minimal neurocognitive response to intravenous steroids. However, he responded to Rituximab with significant improvement in cognition but limited improvement in motor skills thus far. We also explore the possible association with recent epidural platelet rich plasma (PRP) therapy treatment.
Design/Methods: NA
Results: NA
Conclusions: NA
Disclosure: Dr. Alani has nothing to disclose. Dr. Rossi has nothing to disclose. Dr. Hoffmann has nothing to disclose. Dr. Benes-Cases has nothing to disclose. Dr. Sharma has nothing to disclose. Dr. Tsakadze has nothing to disclose.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
